{"id":"W2076746778","doi":"10.1200/jco.2009.23.8022","title":"Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial","year":2009,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Docetaxel; Trastuzumab; Cyclophosphamide; Doxorubicin; Breast cancer; Chemotherapy; Internal medicine; Immunohistochemistry; Oncology; Cancer; Fluorouracil; Group A; Human Epidermal Growth Factor Receptor 2; Group B","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004966697,0.0007960197,0.001865371,0.0003353239,0.0002838314,0.001567591,0.0009657444,0.002823088,0.001878166],"category_scores_gemma":[0.01089721,0.0002869744,0.001142834,0.0006020864,0.0004496574,0.001090308,0.0002876875,0.004668172,0.0003416904],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008990318,"about_ca_system_score_gemma":0.0007783789,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007531421,"about_ca_topic_score_gemma":0.002598167,"domain_scores_codex":[0.9981545,0.001137461,0.0001917278,0.0001393465,0.0002418706,0.0001351471],"domain_scores_gemma":[0.9932201,0.004349567,0.001011725,0.000157974,0.000651363,0.0006093011],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3280881,0.002379874,0.04292514,0.009834438,0.007496517,0.0007026954,0.0003676245,0.001532861,0.002453199,0.001852534,0.3608094,0.2415577],"study_design_scores_gemma":[0.3913797,0.06023355,0.2117073,0.01181173,0.03654002,0.001706408,0.0008432677,0.01818494,0.005036949,0.004855985,0.2571144,0.0005857315],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.3852008,0.211207,0.0008002958,0.3045889,0.07593244,0.0009034899,0.004867281,0.0002507179,0.01624928],"genre_scores_gemma":[0.695692,0.04081996,0.001537967,0.1587392,0.0900913,0.001166394,0.002505843,0.0001287929,0.009318588],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.004966697,"threshold_uncertainty_score":0.02626669,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07052517594692452,"score_gpt":0.409836656703913,"score_spread":0.3393114807569885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}